Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

gwpharma

GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial

May 7, 2019 Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc

GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …
News

FDA approves first two drugs for transthyretin amyloid cardiomyopathy

May 7, 2019 Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma

The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …
News
450px-official_portrait_of_matt_hancock_crop_2

Health Secretary Matt Hancock says he will not rule out ‘compulsory vaccination’

May 7, 2019 Manufacturing and Production, Sales and Marketing Matt Hancock, infectious diseases, pharma, public health, vaccines

Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …
News
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
News

Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…

May 2, 2019 Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma

Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …
News
dw-anzcxqaqavhl

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019 Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …
News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
News
gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019 Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …
News

The price of access: Can the NHS afford Orkambi?

April 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …
Feature
shutterstock_243110086

Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients

April 29, 2019 Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma

The European Commission has authorised the use of Sanofi and Lexicon’s Zynquista (sotagliflozin) in Europe in the treatment of specific …
News

Gilead subsidiary Kite Pharma to open CAR-T manufacturing facility in Maryland

April 29, 2019 Manufacturing and Production, Sales and Marketing CAR-T, Gilead, Manufacturing Facility, Maryland, kite pharma

Gilead Sciences subsidiary Kite Pharma has announced plans to open a new CAR-T manufacturing facility in Frederick County, Maryland (US). …
News
credit_-_daniel_leal-olivas-afp

AZ and MSD’s Lynparza secures CHMP nod in first-line BRCA-mutated ovarian cancer

April 29, 2019 Sales and Marketing AstraZeneca, CHMP, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s Lynparza (olaparib) has received a positive opinion from the EMA’s Committee for Medicinal Products for Human Use …
News

India hits back at claims they are leading source of counterfeit drugs

April 29, 2019 Sales and Marketing

India has rejected claims that they, along with China, are the chief source of counterfeit medicines around the world. In …
News
opioid_pills

Opioids to be labelled with addiction warning in UK

April 29, 2019 Sales and Marketing

All opioid medicines sold in the UK will be labelled with a warning as to the potential for addiction, Health …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025